2344 related articles for article (PubMed ID: 1470919)
1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Devane WA; Hanus L; Breuer A; Pertwee RG; Stevenson LA; Griffin G; Gibson D; Mandelbaum A; Etinger A; Mechoulam R
Science; 1992 Dec; 258(5090):1946-9. PubMed ID: 1470919
[TBL] [Abstract][Full Text] [Related]
2. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
[TBL] [Abstract][Full Text] [Related]
3. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.
Vogel Z; Barg J; Levy R; Saya D; Heldman E; Mechoulam R
J Neurochem; 1993 Jul; 61(1):352-5. PubMed ID: 8515284
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.
Fride E; Mechoulam R
Eur J Pharmacol; 1993 Feb; 231(2):313-4. PubMed ID: 8384116
[TBL] [Abstract][Full Text] [Related]
5. Effects of anandamide on cannabinoid receptors in rat brain membranes.
Childers SR; Sexton T; Roy MB
Biochem Pharmacol; 1994 Feb; 47(4):711-5. PubMed ID: 8129747
[TBL] [Abstract][Full Text] [Related]
6. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.
Weidenfeld J; Feldman S; Mechoulam R
Neuroendocrinology; 1994 Feb; 59(2):110-2. PubMed ID: 8127398
[TBL] [Abstract][Full Text] [Related]
7. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
[TBL] [Abstract][Full Text] [Related]
8. Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor.
Hampson AJ; Hill WA; Zan-Phillips M; Makriyannis A; Leung E; Eglen RM; Bornheim LM
Biochim Biophys Acta; 1995 Nov; 1259(2):173-9. PubMed ID: 7488638
[TBL] [Abstract][Full Text] [Related]
9. Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist.
Ueda N; Yamamoto K; Yamamoto S; Tokunaga T; Shirakawa E; Shinkai H; Ogawa M; Sato T; Kudo I; Inoue K
Biochim Biophys Acta; 1995 Jan; 1254(2):127-34. PubMed ID: 7827116
[TBL] [Abstract][Full Text] [Related]
10. Biochemistry of the endogenous ligands of cannabinoid receptors.
Di Marzo V; Deutsch DG
Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.
Seltzman HH; Fleming DN; Thomas BF; Gilliam AF; McCallion DS; Pertwee RG; Compton DR; Martin BR
J Med Chem; 1997 Oct; 40(22):3626-34. PubMed ID: 9357529
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.
Devane WA; Axelrod J
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6698-701. PubMed ID: 8022836
[TBL] [Abstract][Full Text] [Related]
13. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Paria BC; Das SK; Dey SK
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154
[TBL] [Abstract][Full Text] [Related]
14. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.
Crawley JN; Corwin RL; Robinson JK; Felder CC; Devane WA; Axelrod J
Pharmacol Biochem Behav; 1993 Dec; 46(4):967-72. PubMed ID: 7906042
[TBL] [Abstract][Full Text] [Related]
15. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
16. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
17. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V
Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192
[TBL] [Abstract][Full Text] [Related]
18. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.
Kimura T; Ohta T; Watanabe K; Yoshimura H; Yamamoto I
Biol Pharm Bull; 1998 Mar; 21(3):224-6. PubMed ID: 9556149
[TBL] [Abstract][Full Text] [Related]
19. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.
Felder CC; Nielsen A; Briley EM; Palkovits M; Priller J; Axelrod J; Nguyen DN; Richardson JM; Riggin RM; Koppel GA; Paul SM; Becker GW
FEBS Lett; 1996 Sep; 393(2-3):231-5. PubMed ID: 8814296
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and behavioral evaluation of alkylated anandamide analogs.
Adams IB; Ryan W; Singer M; Razdan RK; Compton DR; Martin BR
Life Sci; 1995; 56(23-24):2041-8. PubMed ID: 7776830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
